Lv5
900 积分 2023-11-13 加入
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
2天前
已完结
A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
5个月前
已完结
Visualization and targeting of LGR5+ human colon cancer stem cells
5个月前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
5个月前
已完结
Development of a Novel Peptide-Based PET Tracer [68Ga]Ga-DOTA-BP1 for BCMA Detection in Multiple Myeloma
6个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
6个月前
已完结
c-Met pathway in human malignancies and its targeting by natural compounds for cancer therapy
7个月前
已完结
Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies
7个月前
已完结
Unlocking the potential of bispecific ADCs for targeted cancer therapy
7个月前
已完结
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
7个月前
已完结
皖公网安备34019202002308
